Management of Acute Hypertension in Patients with Bradycardia and Coronary Artery Disease

Introduction to Preferred Medication

• The European Society of Cardiology recommends intravenous nitroglycerin as the medication of choice for patients with acutely elevated blood pressure, heart rate less than 60 bpm, and coronary artery disease, because it reduces afterload and myocardial oxygen demand without causing further bradycardia or heart block 1, 2, 3

Contraindications for Beta-Blockers

• The European Society of Cardiology guidelines specifically list bradycardia as a contraindication for all beta-blockers in hypertensive emergencies, including labetalol 1, 2
• Labetalol, esmolol, and metoprolol are all explicitly contraindicated in patients with bradycardia (heart rate <60 bpm), as they will worsen the heart rate and potentially cause heart block or cardiac arrest 1, 2, 3

Optimal Use of Nitroglycerin

• Nitroglycerin reduces afterload without increasing heart rate, making it ideal when beta-blockade cannot be used, and it specifically benefits patients with coronary artery disease by dilating coronary arteries and potentially increasing collateral blood flow 1, 2, 4
• The American College of Cardiology/American Heart Association guidelines identify nitroglycerin as an agent of choice for acute coronary syndromes with hypertension, particularly when tachycardia is absent (making beta-blockade less critical) 3

Dosing and Administration of Nitroglycerin

• Start intravenous nitroglycerin at 5 mcg/min and increase by 5 mcg/min every 5 minutes until blood pressure is controlled or symptoms resolve 1, 2

Alternative Agents

• The European Society of Cardiology recommends nicardipine (a calcium channel blocker) as the best alternative if nitroglycerin is ineffective or not tolerated, as it reduces afterload without affecting heart rate or conduction 1, 2, 3
• Clevidipine is another calcium channel blocker option with very rapid onset (2-3 minutes) and short duration, allowing precise titration; start at 2 mg/h and increase every 2 minutes 1, 2

Critical Pitfalls to Avoid

• Do not use sodium nitroprusside as first-line in this patient, as it decreases regional coronary blood flow in patients with coronary abnormalities and increases myocardial damage after acute myocardial infarction compared to nitroglycerin 1, 2
• Avoid any beta-blocker (labetalol, esmolol, metoprolol) given the heart rate <60 bpm, as this represents an absolute contraindication and could precipitate complete heart block or cardiac arrest 1, 2, 3

Monitoring Requirements

• Continuous cardiac monitoring is essential to track heart rate and rhythm, watching for further bradycardia, heart block, or arrhythmias 1, 2
• Frequent blood pressure measurements (every 2-5 minutes initially) are needed during titration to avoid hypotension 1, 2
• Assess for signs of ongoing ischemia (chest pain, ECG changes, troponin elevation) as blood pressure is lowered 1, 2, 4